Literature DB >> 22508915

Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.

Ashley L Buchanan1, Grace Montepiedra, Patricia A Sirois, Betsy Kammerer, Patricia A Garvie, Deborah S Storm, Sharon L Nichols.   

Abstract

OBJECTIVE: Nonadherence to antiretroviral therapy among children/youth with HIV often is associated with disease progression. This study examined the agreement between child and caregiver perceptions of barriers to adherence and factors associated with these barriers.
METHODS: Children/youth with perinatally acquired HIV and their parents/caregivers (n = 120 dyads) completed a questionnaire about 19 potential barriers to adherence to the child's antiretroviral therapy regimen. Agreement between the 2 reports was measured via the kappa statistic. Factors associated with the barriers were assessed by using multiple logistic regression.
RESULTS: Of the 120 children, 55% were African American, 54% were boys, and the average age was 12.8 years. The most frequently reported barrier by either the caregiver or youth was "forgot." There were varying degrees of agreement between child and caregiver on the following barriers: "forgot," "taste," "child was away from home," "child refused," and "child felt good." Children who knew their HIV status were more likely to report logistical barriers, such as scheduling issues. Children with a biological parent as their caregiver were more likely to report regimen or fear of disclosure as a barrier.
CONCLUSIONS: Lack of agreement was observed for more than half of the studied barriers, indicating discrepancies between children's and caregivers' perceptions of factors that influence medication-taking. The findings suggest a need for interventions that involve both child and caregiver in the tasks of remembering when to administer the child's medications, sustaining adherence, and appropriately transitioning medication responsibility to the youth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508915      PMCID: PMC3340587          DOI: 10.1542/peds.2011-1740

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

Review 1.  Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Authors:  C C Carpenter; D A Cooper; M A Fischl; J M Gatell; B G Gazzard; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Saag; M Schechter; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Barriers to HAART adherence among human immunodeficiency virus-infected adolescents.

Authors:  Debra A Murphy; Moussa Sarr; Stephen J Durako; Anna-Barbara Moscicki; Craig M Wilson; Larry R Muenz
Journal:  Arch Pediatr Adolesc Med       Date:  2003-03

3.  Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.

Authors:  Susan Brogly; Paige Williams; George R Seage; James M Oleske; Russell Van Dyke; Kenneth McIntosh
Journal:  JAMA       Date:  2005-05-11       Impact factor: 56.272

4.  Assessing family sharing of diabetes responsibilities.

Authors:  B J Anderson; W F Auslander; K C Jung; J P Miller; J V Santiago
Journal:  J Pediatr Psychol       Date:  1990-08

5.  Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Authors:  Paige L Williams; Deborah Storm; Grace Montepiedra; Sharon Nichols; Betsy Kammerer; Patricia A Sirois; John Farley; Kathleen Malee
Journal:  Pediatrics       Date:  2006-11-13       Impact factor: 7.124

6.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

Authors:  S L Catz; J A Kelly; L M Bogart; E G Benotsch; T L McAuliffe
Journal:  Health Psychol       Date:  2000-03       Impact factor: 4.267

7.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

8.  The reliability of reports of medical adherence from children with HIV and their adult caregivers.

Authors:  Curtis Dolezal; Claude Mellins; Elizabeth Brackis-Cott; Elaine J Abrams
Journal:  J Pediatr Psychol       Date:  2003 Jul-Aug

9.  The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.

Authors:  Claude Ann Mellins; Elizabeth Brackis-Cott; Curtis Dolezal; Elaine J Abrams
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

Review 10.  Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Authors:  Edward J Mills; Jean B Nachega; David R Bangsberg; Sonal Singh; Beth Rachlis; Ping Wu; Kumanan Wilson; Iain Buchan; Christopher J Gill; Curtis Cooper
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  44 in total

1.  Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.

Authors:  Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

2.  Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants.

Authors:  Parya Saberi; Torsten B Neilands; Eric Vittinghoff; Mallory O Johnson; Margaret Chesney; Susan E Cohn
Journal:  AIDS Patient Care STDS       Date:  2015-01-23       Impact factor: 5.078

3.  Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection.

Authors:  Shun Zhang; George Rust; Kathryn Cardarelli; Jesus Felizzola; Mesfin Fransua; Harold G Stringer
Journal:  AIDS Care       Date:  2015-03-27

4.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

Review 5.  The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities.

Authors:  Brian C Zanoni; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2014-03       Impact factor: 5.078

6.  Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment Drug.

Authors:  Julie A Mennella; Phoebe S Mathew; Elizabeth D Lowenthal
Journal:  Clin Ther       Date:  2017-09-18       Impact factor: 3.393

7.  Qualitative Comparison of Barriers to Antiretroviral Medication Adherence Among Perinatally and Behaviorally HIV-Infected Youth.

Authors:  Errol L Fields; Laura M Bogart; Idia B Thurston; Caroline H Hu; Margie R Skeer; Steven A Safren; Matthew J Mimiaga
Journal:  Qual Health Res       Date:  2017-04-11

8.  In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents.

Authors:  Rajith K R Rajoli; David J Back; Steve Rannard; Caren Freel Meyers; Charles Flexner; Andrew Owen; Marco Siccardi
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

9.  Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.

Authors:  Rolando M Viani; Carmelita Alvero; Terry Fenton; Edward P Acosta; Rohan Hazra; Ellen Townley; Debra Steimers; Sherene Min; Andrew Wiznia
Journal:  Pediatr Infect Dis J       Date:  2015-11       Impact factor: 2.129

10.  iSAY (incentives for South African youth): Stated preferences of young people living with HIV.

Authors:  Omar Galárraga; Caroline Kuo; Bulelwa Mtukushe; Brendan Maughan-Brown; Abigail Harrison; Jackie Hoare
Journal:  Soc Sci Med       Date:  2020-08-29       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.